Search the Newsreel

AMN Healthcare Services Inc Stock 12‑Month Price Target Raised to $34.29, Implies 11% Upside

AMN Healthcare Services Inc's average 12-month price target has been increased to $34.29 by 7 analysts, up from $33.29, with forecasts ranging from $26 to $40 per share. This new target suggests an 11% potential upside from the August 6 closing price. The consensus …

AMN Healthcare Services Inc (NYSE:AMN) Receives Average Recommendation of "Hold" from Analysts

Analysts have given AMN Healthcare Services Inc (NYSE:AMN) an average "Hold" rating, with a 12-month price target below its current stock price. Despite a challenging staffing market, the company reported strong second-quarter results, significantly exceeding EPS and revenue expectations, driven by growth in travel …

AMN Healthcare Services (NYSE:AMN) Sets New 52-Week High Following Analyst Upgrade

AMN Healthcare Services (NYSE:AMN) reached a new 52-week high of $36.86 after UBS Group raised its price target to $35.00, although maintaining a neutral rating. The company reported strong second-quarter results, significantly exceeding adjusted EPS and revenue expectations, and provided optimistic third-quarter revenue guidance. …

AMN Healthcare Services 2Q 2026: Revenue $673.2M, EPS $0.53— 10-Q Summary

AMN Healthcare Services Inc. reported its second-quarter 2026 results, showing a return to profitability with net income of $21.2 million and diluted EPS of $0.53, an improvement from a loss in the prior-year quarter. Revenue increased to $673.2 million, driven by strong growth in …

AMN Healthcare Services Crushes Q2 2026 Profit Estimates by 305.3%

AMN Healthcare Services (NYSE:AMN) reported a significant beat in its Q2 2026 earnings, with adjusted diluted EPS of $0.77 against an estimated $0.19, reflecting a 305.3% beat. Revenue increased 2.0% year-over-year to $673.2M, driven by strong performance in the Nurse and Allied Solutions division. …

AMN Healthcare (NYSE: AMN) posts $2.05B H1 revenue and strong cash flow

AMN Healthcare Services reported a significant increase in first-half 2026 revenue to $2.05 billion, a 52% rise year-over-year, primarily driven by labor disruption staffing in its nurse and allied solutions segment. The company returned to profitability with a net income of $83.3 million for …

Amneal (AMRX) Upgraded to Buy: What Does It Mean for the Stock?

Amneal Pharmaceuticals (AMRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks …

AMN Healthcare Services (NYSE:AMN) Stock Price Up 16.5% Following Strong Earnings

Jamna Auto Industries Greenlights ₹47 Crore Leaf Spring Plant in Jharkhand With 1,500 MT Monthly Capacity

Is ACADIA Pharmaceuticals (ACAD) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Acadia Pharmaceuticals (ACAD) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a …

Jamna Auto Q1FY27 profit rises 6%, EBITDA margin expands to 13.92%

Amneal Pharmaceuticals' (NASDAQ:AMRX) Strong Earnings Are Of Good Quality

Amneal Pharmaceuticals reported healthy earnings, but the stock price remained stable. The company's profit was impacted by US$81m in unusual expenses, which are likely one-off events, suggesting higher future profits. The article highlights that these unusual items might cause Amneal Pharmaceuticals' statutory profit to …

AMN Healthcare Services Q2 2026 Earnings Call Transcript

AMN Healthcare Services reported Q2 2026 earnings that exceeded expectations, with consolidated revenue up 2% year-over-year to $673 million and adjusted EPS at $0.77. The company saw strong performance in Nurse and Allied Solutions, driven by increased demand and improved fill rates, while Physician …

AMN Healthcare Services (NYSE:AMN) Issues Quarterly Earnings Results

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS

AMN Healthcare Services, Inc. announced its second-quarter 2026 financial results, with consolidated revenue reaching $673 million, a 2% increase year-over-year, and adjusted diluted EPS of $0.77. The company's performance was driven by growth in travel nurse, allied, and search segments, exceeding guidance. AMN Healthcare …

AMN Healthcare (AMN) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, AMN Healthcare Services (AMN) reported revenue of $673.24 million, up 2.3% over the same period last year. EPS came in at $0.77, compared to $0.30 in the year-ago quarter. The reported revenue represents a surprise of +7.55% over …

AMN Healthcare Services (NYSE:AMN) Delivers Strong Q2 CY2026 Numbers, Stock Jumps 11.5%

AMN Healthcare Services (NYSE:AMN) reported strong Q2 CY2026 results, surpassing Wall Street's revenue and EPS expectations. The healthcare staffing company saw a 2.3% year-on-year revenue increase to $673.2 million and a non-GAAP profit of $0.77 per share, leading to an 11.5% jump in its …

AMN Healthcare soars 11% on strong Q2 beat and guidance

AMN Healthcare Services Inc. reported stronger-than-expected second-quarter results, with adjusted EPS of $0.77 and revenue of $673.2 million, surpassing analyst consensus. The company's performance was driven by growth in travel nursing, allied staffing, search services, and labor disruption revenue, leading to an 11.7% surge …

AMN Healthcare Services (AMN) Q2 Earnings and Revenues Beat Estimates

AMN Healthcare Services (AMN) reported strong Q2 2026 earnings, beating Zacks Consensus Estimates for both earnings per share ($0.77 vs. $0.22) and revenues ($673.24 million vs. $619.11 million). The company has consistently surpassed revenue estimates over the past year, and its stock has significantly …

AMN Healthcare (NYSE:AMN) Surges After Blowout Q2 Earnings Beat

AMN Healthcare (NYSE:AMN) reported strong second-quarter earnings that significantly surpassed analyst expectations, leading to a 13.1% surge in shares during after-hours trading. The company posted higher-than-expected revenue of $673.2 million and adjusted EPS of $0.77, well above the $0.19 analysts had modeled. This positive …

(AMN) AMN Healthcare Services, Inc. Expects Q3 Revenue Range $640.0M - $655.0M

AMN Healthcare Services, Inc. (AMN) forecasts its third-quarter revenue to be between $640.0 million and $655.0 million. This announcement follows their Q2 revenue report of $673.2 million, surpassing FactSet estimates of $628.4 million, and adjusted EPS of $0.77 per share, also exceeding estimates. The …

AMN Healthcare earnings up next: Can core staffing stabilize?

AMN Healthcare Services Inc. is set to report second-quarter earnings, with analysts focusing on whether its core healthcare staffing business is stabilizing after a strong first quarter driven by one-time labor disruption revenue. The company faces a challenge in returning to normalized growth, with …

AMN Healthcare search revenue grew 27% after Q2 results exceeded guidance

AMN Healthcare Services (AMN) Earnings Date and Reports 2026

Earnings Flash (AMN) AMN Healthcare Services, Inc. Posts Q2 Adjusted EPS $0.77 per Share, vs. FactSet Est of $0.19

AMN Healthcare Services, Inc. (AMN) announced its Q2 adjusted EPS of $0.77 per share, significantly surpassing the FactSet estimate of $0.19. The company also reported Q2 revenue of $673.2 million, exceeding the FactSet estimate of $628.4 million, and provided Q3 revenue guidance ranging from …

AMN Healthcare Services (AMN) Q2 Earnings Report Preview: What To Look For

AMN Healthcare Services (NYSE:AMN) is set to release its Q2 earnings report this Thursday after market close. Analysts anticipate a 4.5% year-on-year revenue decline, an improvement from the 11.1% decrease in the same quarter last year. The company has a history of exceeding Wall …

Truist Financial Maintains AMN Healthcare Services(AMN.US) With Buy Rating

Truist Financial has reiterated its Buy rating on AMN Healthcare Services (AMN.US). The firm also maintained its price target of $105.00 for the company.

UBS raises Amneal Pharmaceuticals price target on biosimilar growth

UBS has increased its price target for Amneal Pharmaceuticals Inc. to $25.00 from $23.00, maintaining a Buy rating. This adjustment follows the company's strong second-quarter earnings beat and raised guidance, despite a recent stock pullback. UBS anticipates significant growth from Amneal's biosimilar and generic …

Did Strong Q2 Results and Higher 2026 Revenue Guidance Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative?

Arrowstreet Capital Limited Partnership Trims Stake in Amneal Pharmaceuticals, Inc. $AMRX

Amneal Pharma A earnings beat by $0.07, revenue topped estimates

Amneal Pharma A (NASDAQ: AMRX) reported strong second-quarter results, surpassing analyst estimates with EPS of $0.300 and revenue of $796.2 million. The company also provided optimistic full-year 2026 guidance, expecting EPS between $0.960-$1.060 and revenue between $3.100B-$3.200B. AMRX stock has shown significant growth, increasing …

Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance

AMN Healthcare Services Inc (AMN) Shares Fall 3.1% -- GF Value Says Still Overvalued

AMN Healthcare Services Inc (AMN) shares dropped 3.1% to $33.63, with GuruFocus's GF Value indicating the stock is 10.9% overvalued compared to its estimate of $30.32. The company's GF Score of 63/100 points to strong profitability but limited growth potential. Insider selling and a …

Earnings Preview: AMN to Report Financial Results Post-market on August 06

This article announces that AMN Healthcare Services (AMN) is scheduled to report its financial results post-market on August 06. The report will cover the quarter ended June 2024, with analysts expecting adjusted earnings of $1.00 per share and revenue of $917.9 million. Investors will …

Amneal (AMRX) Stock Looks About Fair Value On Current Earnings

First Trust Advisors LP Acquires 116,873 Shares of Amneal Pharmaceuticals, Inc. $AMRX